Performance statistics
SPECIFICITY 98.04%
SENSITIVITY 93.75%
ACCURACY 97.48%
Rapid SARS-CoV-2 Antigen Test Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein from SARS-CoV-2 in nasopharyngeal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first 7 days of symptom onset.
Carefully insert the swab into the nostril and swab over the surface of the posterior nasopharynx.
Add 8 drops of extraction buffer into the extraction tube. Leave the swab in the extraction buffer for 1 minute.
Add 2-3 drops of test specimen from the extraction tube on the test card and read the results at 15-20 minutes.
See IFU (Instructions For Use) sheet inside the device kit for more details.
Please refer to the IFU information sheet and Full User Product Training document for detailed device information.
For answers to commonly asked questions and more information about the Boson Rapid SARS Co-V2 device, please visit our FAQs page